SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
FROM | TO | |
---|---|---|
IMMURON LIMITED | 05/12/2008 | |
ANADIS LIMITED | 05/12/2008 |
Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414The suspension of trading in the securities of Immuron Limited will be lifted from the commencement of trading on 24 September 2021, following the release by IMC of an announcement regarding a planned acquisition | 23/09/2021 |
The Company has been pursuing a major acquisition of a private biotechnology company focused on the development of innovative vaccine technologies. After filing with the ASX a detailed ASX In-Principal Advice Application and subsequent lengthy discussions and exchanges with the ASX. ASX advised Immuron that based on the information provided to date, ASX does not currently have sufficient information to enable it to be satisfied that the combined group after the proposed acquisition would meet those requirements under chapters 1 and 2 of the ASX Listing Rules. Immuron as a result is now unable to satisfy the pre-conditions for this proposed acquisition due to the expiration of the existing contractual timetable and will not proceed with the proposed acquisition in its present form. There are no break fees associated with being unable to satisfy the preconditions existing contractual timetable, however professional fees associated with thistransaction over the past 4 months are approximately $450k plus GST. | 23/09/2021 |
The company lodges its Preliminary Final Report. | 31/08/2021 |
Immuron is required to lodge a formal In-Principle Advice Application in accordance with Guidance Note 12. That application has now been received by ASX, and the ASX is currently considering the application in connection with Immuron's suitability for admission to the official list of ASX Limited. Immuron acknowledges that its securities will remain suspended until it has met the requirements set out in Guidance Note 12. | 07/07/2021 |
The company is limited in the detail that can be released at this time while the ASX consider a submission it has requested from the Company in relation to ASX Listing Rule 11.1 and 11.2 and Guidance Note 12. | 08/06/2021 |
The securities of Immuron Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of IMC, pending the release of an announcement regarding a planned acquisition. | 31/05/2021 |
we understand that on or about this date the company consolidated its shares 1 for 40 | 17/11/2014 |
The suspension of trading in the securities of Immuron Limited (the "Company") will be lifted immediately, following the release of an announcement of a capital raising. Security Code: IMC | 23/04/2012 |
The securities of Immuron Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding a capital raising | 20/04/2012 |
name changed from Anadis Limited | 05/12/2008 |
DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
---|---|---|---|---|
30/06/2022 | Daniel Pollock | 50,000 | $0.076 | $3,800.00 |
20/11/2020 | Daniel Pollock | -100,000 | $0.260 | $26,000.00 |
23/06/2020 | Daniel Pollock | -100,000 | $0.325 | $32,500.00 |
17/06/2020 | Peter Anastasiou | -4,184,808 | $0.312 | $1,306,326.00 |
11/06/2020 | Daniel Pollock | -100,000 | $0.405 | $40,480.00 |
NAME | TITLE | DATE OF APPT |
---|---|---|
Paul Brennan | Chairman | 16/03/2022 |
Steven Lydeamore | CEO | 27/06/2022 |
Jerry Kanellos | COO | 28/07/2015 |
Jeannie Joughin | Non Exec Director | 01/06/2024 |
Daniel Pollock | Non Exec Director | 11/10/2012 |
Ravi Savarirayan | Director | 07/04/2017 |
Phillip Hains | Company Secretary |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|
Date of first appointment, title may have changed.